An interventional study of Management training and data feedback in HIV/AIDS, sponsored by Instituto Nacional de Salud Publica, Mexico. Terminated at 1 site in Nigeria. Per ClinicalTrials.gov, last updated 2020-08-05.
Sponsored by Instituto Nacional de Salud Publica, Mexico · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 25 studies in Acquired Immunodeficiency Syndrome with a site in Nigeria — 3 open to participants now, 4 under way, 1 of them phase 3. Acquired Immunodeficiency Syndrome · Nigeria.
Among the 25 studies in Acquired Immunodeficiency Syndrome with a site in Nigeria, this one is the 21st largest by enrollment of the 22 interventional ones that give a count, is one of 4 that started in 2017, is one of 15 with no phase, and was the 11th registered.
3,037 studies on the registry are indexed under Acquired Immunodeficiency Syndrome; 307 are open to participants now.
Browse Acquired Immunodeficiency Syndrome studies →3 of the 25 studies in Acquired Immunodeficiency Syndrome with a site in Nigeria are open now. Recruiting first, the newest first:
Massachusetts General Hospital · Sites in Nigeria
Ages 16–29
Population Health Research Institute · Sites in Nigeria, Côte D'Ivoire, Ethiopia and 8 more countries
Ages 18+
University of Maryland, Baltimore · Sites in Nigeria, Zambia
Ages 15–24 · Men only · Healthy volunteers
A study can be open while its sites in Nigeria have not opened yet or have stopped. Only those recruiting at a site in Nigeria →
Of the 198 Acquired Immunodeficiency Syndrome studies recruiting now, 118 (60%) set no upper age limit and 67 (34%) stop at 75 or younger; 43 take children under 18; 68 take healthy volunteers.
This study: all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
25 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 4 started in 2017.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 32 is below the median of 96 across 2,252 interventional studies indexed under Acquired Immunodeficiency Syndrome.
Median enrollment 466 across the 22 interventional studies, 342 across the 3 observational. Of the 19 that completed or were terminated, 6 (32%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 25 has an industry lead sponsor. The 10 most frequent:
Instituto Nacional de Salud Publica, Mexico is the lead sponsor of 31 studies on the registry; none are open to participants now.
Instituto Nacional de Salud Publica, Mexico has 2 studies filed under Acquired Immunodeficiency Syndrome — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 25 studies in Acquired Immunodeficiency Syndrome with a site in Nigeria, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study seeks to measure the costs associated with HIV prevention service delivery to female sex workers (FSW) in Nigeria, as well as examine the relationship between management practices at the community-based organizations (CBOs) and costs. To complete these goals, the study will collect both retrospective and prospective data from CBOs and from centralized information from study partners (Society for Family Health, SFH). In the prospective section of the study, CBOs will be sampled and assigned to either treatment or control groups. Data collected at the CBOs will be aggregated by the CBO managers, and those in the treatment group will receive feedback on their performance on a monthly basis. Those in the treatment group will additionally receive a management training to guide their management practices. Researchers hypothesize that there will be improvements in management indicators and therefore decreases in costs at CBOs in the treatment group. Results will be disseminated to local, national, and international stakeholders.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The treatment group in the study will receive a 5-day training. The first two days of the training will consist of introducing the data collection tools and collecting baseline data. Days three through five of the training will consist of a variety of management topics. On a monthly basis, the treatment group will receive data visualizations that will compare their site's performance that month to pervious performance and to other sites in the study. Both treatment and control groups will collect information regarding input costs and number of services provided on a monthly basis.
Behavioral: Management training and data feedback
The control group will receive only a 2-day training which will focus on data collection alone. Both treatment and control groups will collect information regarding input costs and number of services provided on a monthly basis.
The management training will consist of a variety of management topics, such as financial, workplace and staff management. The training will include a number of tools that the managers will be expected to bring back with them and use regularly at their site. There will be monthly refresher trainings for the managers via an online platform, where participants will interact about the topics covered in the training and others relevant to their work as managers. Participants will also receive monthly visualizations that compare the data that they enter via tablet monthly to both (1) their baseline data, and (2) to other sites' data. Outcomes that will be measured and reported back to sites include cost per client tested, number of condoms distributed, and number of FSW reached by educational interventions.
Change in cost per female sex worker reached by HIV education services
This measures the total cost of HIV education provision, divided by the number of female sex workers (FSWs) reached by the service.
Time frame: Two years
Change in cost per female sex worker tested
This measures the total cost of HIV testing and counseling, divided by the number of FSWs tested.
Time frame: Two years
Change in cost per female sex worker treated for STIs (sexually transmitted infections)
This measures the total cost of STI treatment, divided by the number of FSWs treated for any STI.
Time frame: Two years
Change in cost per female sex worker tested positive
This measures the total cost of HIV testing and counseling, divided by the number of FSWs tested positive for HIV.
Time frame: Two years
Productivity of HIV education
Productivity of the organizations will be measured as the number of outputs produced for the HIV education intervention-number of FSW reached by HIV education.
Time frame: Two years
Productivity of HIV testing
Productivity of the organizations will be measured as the number of outputs produced for the HIV testing and counseling interventions-number of FSW tested for HIV.
Time frame: Two years
Productivity of STI treatment
Productivity of the organizations will be measured as the number of outputs produced for the STI treatment intervention-number of FSW treated for STIs.
Time frame: Two years
Job satisfaction
Measured through a composite score of five Likert scale questions about satisfaction, answers ranging from 1-5, 1 being "very dissatisfied" and 5 being "very satisfied".
Time frame: Two years
Ran from Aug 2017 to primary completion in Sep 2018, 12 months.
How these figures are worked out, and which studies are left out of them.
This study is terminated, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Acquired Immunodeficiency Syndrome →
Instituto Nacional de Salud Publica, Mexico